The global Circulating Tumor Cells (CTC) market size was US$ 1729 million in 2024 and is forecast to a readjusted size of US$ 4279 million by 2031 with a CAGR of 14.6% during the forecast period 2025-2031.

Circulating Tumor Cells (CTC) Sales Market

Circulating tumor cells (CTC) refer to malignant tumor cells that fall off from primary tumors or metastatic foci and enter the peripheral blood circulation. They are the root cause of tumor recurrence and metastasis, the "seeds" of cancer metastasis, and can spread to distant organs through the blood to form metastatic foci. They are rare, atypical, heterogeneous, and diverse, and are used in early clinical diagnosis, prognosis evaluation, and efficacy monitoring. The clinical application of CTC is mainly concentrated in prognosis judgment, clinical tumor staging, disease monitoring, and efficacy evaluation. In addition, it has a wide range of applications in tumor screening and monitoring, tumor drug/therapy research and development, tumor pathology research, EMT biomarker research, and cancer stem cell research.

At present, the rising incidence of cancer, the demand for early screening, personalized treatment, technology progress and government policy support (such as AJCC, NCCN, and China CSCO guidelines) are all driving the continuous development of the circulating tumor cell (CTC) market. The North American market is technologically advanced, and strict regulation in the European market promotes standardization, with Germany and the United Kingdom leading research and development. Asia-Pacific China is growing rapidly, and the government has introduced policy support (such as "Healthy China 2030"). Demand in India and Southeast Asia is growing, cost-sensitive testing is popular, and localized production in China, India and other countries reduces costs. In the future, technology will develop in the direction of multi-omics integration, AI-assisted analysis, intelligent upgrades, and portability. Of course, it also faces challenges such as technical bottlenecks, high costs, lack of standards, and risks of false negatives.

The global Circulating Tumor Cells (CTC) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

Scope of Circulating Tumor Cells (CTC) Sales Market Report

Report Metric	Details
Report Name	Circulating Tumor Cells (CTC) Sales Market
Forecasted market size in 2031	US$ 4279 million
CAGR	14.6%
Forecasted years	2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)	Testing Equipment and Instruments Kits and Reagents Blood Collection Tubes Others
By Application: (Core Demand Driver vs Emerging Opportunity)	Clinical Diagnosis and Treatment Screening and Monitoring Drug/Therapy Development Tumor Pathology Research Emt Biomarker Research Cancer Stem Cell Research Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company:	Qiagen, Bio-Rad, Johnson & Johnson, Thermo Fisher Scientific, Ikonisys, Miltenyi Biotech, Rarecells, Vitatex, Menarini Silicon Biosystems, Bio-Techne, BioFluidica, Gilupi, BioView, ScreenCell, Wuhan YZY Medical Science & Technology, NanoLite Systems, Watson Biotech, DunWill, Guangzhou Wondfo Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Circulating Tumor Cells (CTC) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Kits and Reagents in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Screening and Monitoring in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Circulating Tumor Cells (CTC) value chain, addressing:

FAQ for this report

What is the Circulating Tumor Cells (CTC) Sales Market size in 2031?

Ans: The Circulating Tumor Cells (CTC) Sales Market size in 2031 will be US$ 4279 million.

Who are the main players in the Circulating Tumor Cells (CTC) Sales Market report?

Ans: The main players in the Circulating Tumor Cells (CTC) Sales Market are Qiagen, Bio-Rad, Johnson & Johnson, Thermo Fisher Scientific, Ikonisys, Miltenyi Biotech, Rarecells, Vitatex, Menarini Silicon Biosystems, Bio-Techne, BioFluidica, Gilupi, BioView, ScreenCell, Wuhan YZY Medical Science & Technology, NanoLite Systems, Watson Biotech, DunWill, Guangzhou Wondfo Biotech

What are the Application segmentation covered in the Circulating Tumor Cells (CTC) Sales Market report?

Ans: The Applications covered in the Circulating Tumor Cells (CTC) Sales Market report are Clinical Diagnosis and Treatment, Screening and Monitoring, Drug/Therapy Development, Tumor Pathology Research, Emt Biomarker Research, Cancer Stem Cell Research, Others

What are the Type segmentation covered in the Circulating Tumor Cells (CTC) Sales Market report?

Ans: The Types covered in the Circulating Tumor Cells (CTC) Sales Market report are Testing Equipment and Instruments, Kits and Reagents, Blood Collection Tubes, Others

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Testing Equipment and Instruments

1.2.3 Kits and Reagents

1.2.4 Blood Collection Tubes

1.2.5 Others

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Clinical Diagnosis and Treatment

1.3.3 Screening and Monitoring

1.3.4 Drug/Therapy Development

1.3.5 Tumor Pathology Research

1.3.6 Emt Biomarker Research

1.3.7 Cancer Stem Cell Research

1.3.8 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Circulating Tumor Cells (CTC) Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Circulating Tumor Cells (CTC) Revenue Market Share by Region (2020-2025)

2.4 Global Circulating Tumor Cells (CTC) Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Circulating Tumor Cells (CTC) Market Size and Prospective (2020-2031)

2.5.2 Europe Circulating Tumor Cells (CTC) Market Size and Prospective (2020-2031)

2.5.3 China Circulating Tumor Cells (CTC) Market Size and Prospective (2020-2031)

2.5.4 Japan Circulating Tumor Cells (CTC) Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Type (2020-2025)

3.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2026-2031)

3.3 Different Types Circulating Tumor Cells (CTC) Representative Players

4 Breakdown Data by Application

4.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Application (2020-2025)

4.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Circulating Tumor Cells (CTC) Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue (2020-2025)

5.1.2 Global Circulating Tumor Cells (CTC) Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Circulating Tumor Cells (CTC) Revenue

5.4 Global Circulating Tumor Cells (CTC) Market Concentration Analysis

5.4.1 Global Circulating Tumor Cells (CTC) Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTC) Revenue in 2024

5.5 Global Key Players of Circulating Tumor Cells (CTC) Head office and Area Served

5.6 Global Key Players of Circulating Tumor Cells (CTC), Product and Application

5.7 Global Key Players of Circulating Tumor Cells (CTC), Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Circulating Tumor Cells (CTC) Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Circulating Tumor Cells (CTC) Market Size by Type (2020-2025)

6.1.2.2 North America Circulating Tumor Cells (CTC) Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Circulating Tumor Cells (CTC) Market Size by Application (2020-2025)

6.1.3.2 North America Circulating Tumor Cells (CTC) Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Circulating Tumor Cells (CTC) Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Circulating Tumor Cells (CTC) Market Size by Type (2020-2025)

6.2.2.2 Europe Circulating Tumor Cells (CTC) Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Circulating Tumor Cells (CTC) Market Size by Application (2020-2025)

6.2.3.2 Europe Circulating Tumor Cells (CTC) Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments and Downstream

6.3.1 China Circulating Tumor Cells (CTC) Revenue by Company (2020-2025)

6.3.2 China Market Size by Type

6.3.2.1 China Circulating Tumor Cells (CTC) Market Size by Type (2020-2025)

6.3.2.2 China Circulating Tumor Cells (CTC) Market Share by Type (2020-2025)

6.3.3 China Market Size by Application

6.3.3.1 China Circulating Tumor Cells (CTC) Market Size by Application (2020-2025)

6.3.3.2 China Circulating Tumor Cells (CTC) Market Share by Application (2020-2025)

6.3.4 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments and Downstream

6.4.1 Japan Circulating Tumor Cells (CTC) Revenue by Company (2020-2025)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Circulating Tumor Cells (CTC) Market Size by Type (2020-2025)

6.4.2.2 Japan Circulating Tumor Cells (CTC) Market Share by Type (2020-2025)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Circulating Tumor Cells (CTC) Market Size by Application (2020-2025)

6.4.3.2 Japan Circulating Tumor Cells (CTC) Market Share by Application (2020-2025)

6.4.4 Japan Market Trend and Opportunities

7 Key Players Profiles

7.1 Qiagen

7.1.1 Qiagen Company Details

7.1.2 Qiagen Business Overview

7.1.3 Qiagen Circulating Tumor Cells (CTC) Introduction

7.1.4 Qiagen Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.1.5 Qiagen Recent Development

7.2 Bio-Rad

7.2.1 Bio-Rad Company Details

7.2.2 Bio-Rad Business Overview

7.2.3 Bio-Rad Circulating Tumor Cells (CTC) Introduction

7.2.4 Bio-Rad Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.2.5 Bio-Rad Recent Development

7.3 Johnson & Johnson

7.3.1 Johnson & Johnson Company Details

7.3.2 Johnson & Johnson Business Overview

7.3.3 Johnson & Johnson Circulating Tumor Cells (CTC) Introduction

7.3.4 Johnson & Johnson Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.3.5 Johnson & Johnson Recent Development

7.4 Thermo Fisher Scientific

7.4.1 Thermo Fisher Scientific Company Details

7.4.2 Thermo Fisher Scientific Business Overview

7.4.3 Thermo Fisher Scientific Circulating Tumor Cells (CTC) Introduction

7.4.4 Thermo Fisher Scientific Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.4.5 Thermo Fisher Scientific Recent Development

7.5 Ikonisys

7.5.1 Ikonisys Company Details

7.5.2 Ikonisys Business Overview

7.5.3 Ikonisys Circulating Tumor Cells (CTC) Introduction

7.5.4 Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.5.5 Ikonisys Recent Development

7.6 Miltenyi Biotech

7.6.1 Miltenyi Biotech Company Details

7.6.2 Miltenyi Biotech Business Overview

7.6.3 Miltenyi Biotech Circulating Tumor Cells (CTC) Introduction

7.6.4 Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.6.5 Miltenyi Biotech Recent Development

7.7 Rarecells

7.7.1 Rarecells Company Details

7.7.2 Rarecells Business Overview

7.7.3 Rarecells Circulating Tumor Cells (CTC) Introduction

7.7.4 Rarecells Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.7.5 Rarecells Recent Development

7.8 Vitatex

7.8.1 Vitatex Company Details

7.8.2 Vitatex Business Overview

7.8.3 Vitatex Circulating Tumor Cells (CTC) Introduction

7.8.4 Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.8.5 Vitatex Recent Development

7.9 Menarini Silicon Biosystems

7.9.1 Menarini Silicon Biosystems Company Details

7.9.2 Menarini Silicon Biosystems Business Overview

7.9.3 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Introduction

7.9.4 Menarini Silicon Biosystems Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.9.5 Menarini Silicon Biosystems Recent Development

7.10 Bio-Techne

7.10.1 Bio-Techne Company Details

7.10.2 Bio-Techne Business Overview

7.10.3 Bio-Techne Circulating Tumor Cells (CTC) Introduction

7.10.4 Bio-Techne Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.10.5 Bio-Techne Recent Development

7.11 BioFluidica

7.11.1 BioFluidica Company Details

7.11.2 BioFluidica Business Overview

7.11.3 BioFluidica Circulating Tumor Cells (CTC) Introduction

7.11.4 BioFluidica Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.11.5 BioFluidica Recent Development

7.12 Gilupi

7.12.1 Gilupi Company Details

7.12.2 Gilupi Business Overview

7.12.3 Gilupi Circulating Tumor Cells (CTC) Introduction

7.12.4 Gilupi Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.12.5 Gilupi Recent Development

7.13 BioView

7.13.1 BioView Company Details

7.13.2 BioView Business Overview

7.13.3 BioView Circulating Tumor Cells (CTC) Introduction

7.13.4 BioView Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.13.5 BioView Recent Development

7.14 ScreenCell

7.14.1 ScreenCell Company Details

7.14.2 ScreenCell Business Overview

7.14.3 ScreenCell Circulating Tumor Cells (CTC) Introduction

7.14.4 ScreenCell Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.14.5 ScreenCell Recent Development

7.15 Wuhan YZY Medical Science & Technology

7.15.1 Wuhan YZY Medical Science & Technology Company Details

7.15.2 Wuhan YZY Medical Science & Technology Business Overview

7.15.3 Wuhan YZY Medical Science & Technology Circulating Tumor Cells (CTC) Introduction

7.15.4 Wuhan YZY Medical Science & Technology Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.15.5 Wuhan YZY Medical Science & Technology Recent Development

7.16 NanoLite Systems

7.16.1 NanoLite Systems Company Details

7.16.2 NanoLite Systems Business Overview

7.16.3 NanoLite Systems Circulating Tumor Cells (CTC) Introduction

7.16.4 NanoLite Systems Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.16.5 NanoLite Systems Recent Development

7.17 Watson Biotech

7.17.1 Watson Biotech Company Details

7.17.2 Watson Biotech Business Overview

7.17.3 Watson Biotech Circulating Tumor Cells (CTC) Introduction

7.17.4 Watson Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.17.5 Watson Biotech Recent Development

7.18 DunWill

7.18.1 DunWill Company Details

7.18.2 DunWill Business Overview

7.18.3 DunWill Circulating Tumor Cells (CTC) Introduction

7.18.4 DunWill Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.18.5 DunWill Recent Development

7.19 Guangzhou Wondfo Biotech

7.19.1 Guangzhou Wondfo Biotech Company Details

7.19.2 Guangzhou Wondfo Biotech Business Overview

7.19.3 Guangzhou Wondfo Biotech Circulating Tumor Cells (CTC) Introduction

7.19.4 Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)

7.19.5 Guangzhou Wondfo Biotech Recent Development

8 Circulating Tumor Cells (CTC) Market Dynamics

8.1 Circulating Tumor Cells (CTC) Industry Trends

8.2 Circulating Tumor Cells (CTC) Market Drivers

8.3 Circulating Tumor Cells (CTC) Market Challenges

8.4 Circulating Tumor Cells (CTC) Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

Rarecells

Menarini Silicon Biosystems

Wuhan Yzy Medical Science&Technology

NanoLite Systems

Watson Biotech

Guangzhou Wondfo Biotech

DunWill

List of Tables

Table 1. Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Circulating Tumor Cells (CTC) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Circulating Tumor Cells (CTC) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Circulating Tumor Cells (CTC) Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Circulating Tumor Cells (CTC) Revenue Share by Region (2020-2025)

Table 6. Global Circulating Tumor Cells (CTC) Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Circulating Tumor Cells (CTC) Revenue Share Forecast by Region (2026-2031)

Table 8. Global Circulating Tumor Cells (CTC) Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2020-2025)

Table 10. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Circulating Tumor Cells (CTC) Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2020-2025)

Table 15. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Circulating Tumor Cells (CTC) Application

Table 18. Global Circulating Tumor Cells (CTC) Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Circulating Tumor Cells (CTC) Market Share by Players (2020-2025)

Table 20. Global Top Circulating Tumor Cells (CTC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTC) as of 2024)

Table 21. Ranking of Global Top Circulating Tumor Cells (CTC) Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Circulating Tumor Cells (CTC) Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Circulating Tumor Cells (CTC), Headquarters and Area Served

Table 24. Global Key Players of Circulating Tumor Cells (CTC), Product and Application

Table 25. Global Key Players of Circulating Tumor Cells (CTC), Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Circulating Tumor Cells (CTC) Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Circulating Tumor Cells (CTC) Revenue Market Share by Company (2020-2025)

Table 29. North America Circulating Tumor Cells (CTC) Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Circulating Tumor Cells (CTC) Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Circulating Tumor Cells (CTC) Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Circulating Tumor Cells (CTC) Revenue Market Share by Company (2020-2025)

Table 33. Europe Circulating Tumor Cells (CTC) Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Circulating Tumor Cells (CTC) Market Size by Application (2020-2025) & (US$ Million)

Table 35. China Circulating Tumor Cells (CTC) Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Circulating Tumor Cells (CTC) Revenue Market Share by Company (2020-2025)

Table 37. China Circulating Tumor Cells (CTC) Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Circulating Tumor Cells (CTC) Market Size by Application (2020-2025) & (US$ Million)

Table 39. Japan Circulating Tumor Cells (CTC) Revenue by Company (2020-2025) & (US$ Million)

Table 40. Japan Circulating Tumor Cells (CTC) Revenue Market Share by Company (2020-2025)

Table 41. Japan Circulating Tumor Cells (CTC) Market Size by Type (2020-2025) & (US$ Million)

Table 42. Japan Circulating Tumor Cells (CTC) Market Size by Application (2020-2025) & (US$ Million)

Table 43. Qiagen Company Details

Table 44. Qiagen Business Overview

Table 45. Qiagen Circulating Tumor Cells (CTC) Product

Table 46. Qiagen Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 47. Qiagen Recent Development

Table 48. Bio-Rad Company Details

Table 49. Bio-Rad Business Overview

Table 50. Bio-Rad Circulating Tumor Cells (CTC) Product

Table 51. Bio-Rad Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 52. Bio-Rad Recent Development

Table 53. Johnson & Johnson Company Details

Table 54. Johnson & Johnson Business Overview

Table 55. Johnson & Johnson Circulating Tumor Cells (CTC) Product

Table 56. Johnson & Johnson Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 57. Johnson & Johnson Recent Development

Table 58. Thermo Fisher Scientific Company Details

Table 59. Thermo Fisher Scientific Business Overview

Table 60. Thermo Fisher Scientific Circulating Tumor Cells (CTC) Product

Table 61. Thermo Fisher Scientific Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 62. Thermo Fisher Scientific Recent Development

Table 63. Ikonisys Company Details

Table 64. Ikonisys Business Overview

Table 65. Ikonisys Circulating Tumor Cells (CTC) Product

Table 66. Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 67. Ikonisys Recent Development

Table 68. Miltenyi Biotech Company Details

Table 69. Miltenyi Biotech Business Overview

Table 70. Miltenyi Biotech Circulating Tumor Cells (CTC) Product

Table 71. Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 72. Miltenyi Biotech Recent Development

Table 73. Rarecells Company Details

Table 74. Rarecells Business Overview

Table 75. Rarecells Circulating Tumor Cells (CTC) Product

Table 76. Rarecells Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 77. Rarecells Recent Development

Table 78. Vitatex Company Details

Table 79. Vitatex Business Overview

Table 80. Vitatex Circulating Tumor Cells (CTC) Product

Table 81. Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 82. Vitatex Recent Development

Table 83. Menarini Silicon Biosystems Company Details

Table 84. Menarini Silicon Biosystems Business Overview

Table 85. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Product

Table 86. Menarini Silicon Biosystems Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 87. Menarini Silicon Biosystems Recent Development

Table 88. Bio-Techne Company Details

Table 89. Bio-Techne Business Overview

Table 90. Bio-Techne Circulating Tumor Cells (CTC) Product

Table 91. Bio-Techne Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 92. Bio-Techne Recent Development

Table 93. BioFluidica Company Details

Table 94. BioFluidica Business Overview

Table 95. BioFluidica Circulating Tumor Cells (CTC) Product

Table 96. BioFluidica Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 97. BioFluidica Recent Development

Table 98. Gilupi Company Details

Table 99. Gilupi Business Overview

Table 100. Gilupi Circulating Tumor Cells (CTC) Product

Table 101. Gilupi Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 102. Gilupi Recent Development

Table 103. BioView Company Details

Table 104. BioView Business Overview

Table 105. BioView Circulating Tumor Cells (CTC) Product

Table 106. BioView Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 107. BioView Recent Development

Table 108. ScreenCell Company Details

Table 109. ScreenCell Business Overview

Table 110. ScreenCell Circulating Tumor Cells (CTC) Product

Table 111. ScreenCell Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 112. ScreenCell Recent Development

Table 113. Wuhan YZY Medical Science & Technology Company Details

Table 114. Wuhan YZY Medical Science & Technology Business Overview

Table 115. Wuhan YZY Medical Science & Technology Circulating Tumor Cells (CTC) Product

Table 116. Wuhan YZY Medical Science & Technology Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 117. Wuhan YZY Medical Science & Technology Recent Development

Table 118. NanoLite Systems Company Details

Table 119. NanoLite Systems Business Overview

Table 120. NanoLite Systems Circulating Tumor Cells (CTC) Product

Table 121. NanoLite Systems Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 122. NanoLite Systems Recent Development

Table 123. Watson Biotech Company Details

Table 124. Watson Biotech Business Overview

Table 125. Watson Biotech Circulating Tumor Cells (CTC) Product

Table 126. Watson Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 127. Watson Biotech Recent Development

Table 128. DunWill Company Details

Table 129. DunWill Business Overview

Table 130. DunWill Circulating Tumor Cells (CTC) Product

Table 131. DunWill Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 132. DunWill Recent Development

Table 133. Guangzhou Wondfo Biotech Company Details

Table 134. Guangzhou Wondfo Biotech Business Overview

Table 135. Guangzhou Wondfo Biotech Circulating Tumor Cells (CTC) Product

Table 136. Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)

Table 137. Guangzhou Wondfo Biotech Recent Development

Table 138. Circulating Tumor Cells (CTC) Market Trends

Table 139. Circulating Tumor Cells (CTC) Market Drivers

Table 140. Circulating Tumor Cells (CTC) Market Challenges

Table 141. Circulating Tumor Cells (CTC) Market Restraints

Table 142. Research Programs/Design for This Report

Table 143. Key Data Information from Secondary Sources

Table 144. Key Data Information from Primary Sources

List of Figures

Figure 1. Circulating Tumor Cells (CTC) Product Picture

Figure 2. Global Circulating Tumor Cells (CTC) Market Share by Type: 2024 VS 2031

Figure 3. Testing Equipment and Instruments Features

Figure 4. Kits and Reagents Features

Figure 5. Blood Collection Tubes Features

Figure 6. Others Features

Figure 7. Global Circulating Tumor Cells (CTC) Market Share by Application: 2024 VS 2031

Figure 8. Clinical Diagnosis and Treatment

Figure 9. Screening and Monitoring

Figure 10. Drug/Therapy Development

Figure 11. Tumor Pathology Research

Figure 12. Emt Biomarker Research

Figure 13. Cancer Stem Cell Research

Figure 14. Others

Figure 15. Circulating Tumor Cells (CTC) Report Years Considered

Figure 16. Global Circulating Tumor Cells (CTC) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Circulating Tumor Cells (CTC) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Circulating Tumor Cells (CTC) Revenue Market Share by Region: 2020 VS 2024

Figure 19. North America Circulating Tumor Cells (CTC) Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. Europe Circulating Tumor Cells (CTC) Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. China Circulating Tumor Cells (CTC) Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. Japan Circulating Tumor Cells (CTC) Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. Global Circulating Tumor Cells (CTC) Market Share by Players in 2024

Figure 24. Global Top Circulating Tumor Cells (CTC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTC) as of 2024)

Figure 25. The Top 10 and 5 Players Market Share by Circulating Tumor Cells (CTC) Revenue in 2024

Figure 26. North America Circulating Tumor Cells (CTC) Market Share by Type (2020-2025)

Figure 27. North America Circulating Tumor Cells (CTC) Market Share by Application (2020-2025)

Figure 28. Europe Circulating Tumor Cells (CTC) Market Share by Type (2020-2025)

Figure 29. Europe Circulating Tumor Cells (CTC) Market Share by Application (2020-2025)

Figure 30. China Circulating Tumor Cells (CTC) Market Share by Type (2020-2025)

Figure 31. China Circulating Tumor Cells (CTC) Market Share by Application (2020-2025)

Figure 32. Japan Circulating Tumor Cells (CTC) Market Share by Type (2020-2025)

Figure 33. Japan Circulating Tumor Cells (CTC) Market Share by Application (2020-2025)

Figure 34. Qiagen Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 35. Bio-Rad Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 36. Johnson & Johnson Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 37. Thermo Fisher Scientific Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 38. Ikonisys Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 39. Miltenyi Biotech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 40. Rarecells Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 41. Vitatex Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 42. Menarini Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 43. Bio-Techne Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 44. BioFluidica Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 45. Gilupi Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 46. BioView Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 47. ScreenCell Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 48. Wuhan YZY Medical Science & Technology Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 49. NanoLite Systems Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 50. Watson Biotech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 51. DunWill Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 52. Guangzhou Wondfo Biotech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4250

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6375

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8500

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-17U17968

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Portable Electric Chemotherapy Pump Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-3C17964

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Liver Metastases Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-0I18138

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Sterile Chemo Dispensing Pin Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-14R17898

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Circulating Tumor Cells (CTC) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Published Date: September 2025

Report Code: QYRE-Auto-17J6258

Global Circulating Tumor Cells (CTC) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

FEATURED COMPANIES

Circulating Tumor Cells (CTC) Sales Market Size

Circulating Tumor Cells (CTC) Sales Market

Scope of Circulating Tumor Cells (CTC) Sales Market Report

Chapter Outline

FAQ for this report

What is the Circulating Tumor Cells (CTC) Sales Market size in 2031?

Who are the main players in the Circulating Tumor Cells (CTC) Sales Market report?

What are the Application segmentation covered in the Circulating Tumor Cells (CTC) Sales Market report?

What are the Type segmentation covered in the Circulating Tumor Cells (CTC) Sales Market report?

FEATURED COMPANIES

RELATED REPORTS

Parenteral Nutrition Market

Single User,